EquityZen Growth Technology Fund LLC - Series 104
Raised
$206K
Investors
12
Min Invest
$0
AltStreet Analysis
·Generated from EDGAR primary sources
EquityZen Growth Technology Fund LLC - Series 104 is a Delaware pooled investment fund filed by EquityZen on 2017-06-01, raising $206K from 12 investors under Rule 506(b) and Section 3(c)(1) exemptions. This is part of EquityZen's pre-IPO secondary platform with over 1,800 related EDGAR entities, representing an early-vintage series-structured fund vehicle.
This pre-IPO fund vehicle uses the common 506(b)/3(c)(1) exemption pairing typical of private pre-IPO pooled funds, avoiding general solicitation while staying under the 100-beneficial-owner threshold. The $17K average investor commitment is consistent with retail-accessible pre-IPO secondary market structures that democratize access to later-stage private company shares.
Data Flags
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
EquityZen Inc
Executive Officer, Director · New York, NY
Shriram Bhashyam
Executive Officer, Director · New York, NY
Assure Fund Management II LLC
Director · Salt Lake City, UT
Mateo Johnson
Executive Officer · Salt Lake City, UT
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.
